Machine learning applications to neuroimaging for glioma detection and classification: An artificial intelligence augmented systematic review

2021 ◽  
Vol 89 ◽  
pp. 177-198
Author(s):  
Quinlan D. Buchlak ◽  
Nazanin Esmaili ◽  
Jean-Christophe Leveque ◽  
Christine Bennett ◽  
Farrokh Farrokhi ◽  
...  
2019 ◽  
Vol 43 (5) ◽  
pp. 1235-1253 ◽  
Author(s):  
Quinlan D. Buchlak ◽  
Nazanin Esmaili ◽  
Jean-Christophe Leveque ◽  
Farrokh Farrokhi ◽  
Christine Bennett ◽  
...  

2021 ◽  
Vol 11 (1) ◽  
pp. 32
Author(s):  
Oliwia Koteluk ◽  
Adrian Wartecki ◽  
Sylwia Mazurek ◽  
Iga Kołodziejczak ◽  
Andrzej Mackiewicz

With an increased number of medical data generated every day, there is a strong need for reliable, automated evaluation tools. With high hopes and expectations, machine learning has the potential to revolutionize many fields of medicine, helping to make faster and more correct decisions and improving current standards of treatment. Today, machines can analyze, learn, communicate, and understand processed data and are used in health care increasingly. This review explains different models and the general process of machine learning and training the algorithms. Furthermore, it summarizes the most useful machine learning applications and tools in different branches of medicine and health care (radiology, pathology, pharmacology, infectious diseases, personalized decision making, and many others). The review also addresses the futuristic prospects and threats of applying artificial intelligence as an advanced, automated medicine tool.


Author(s):  
Anil Babu Payedimarri ◽  
Diego Concina ◽  
Luigi Portinale ◽  
Massimo Canonico ◽  
Deborah Seys ◽  
...  

Artificial Intelligence (AI) and Machine Learning (ML) have expanded their utilization in different fields of medicine. During the SARS-CoV-2 outbreak, AI and ML were also applied for the evaluation and/or implementation of public health interventions aimed to flatten the epidemiological curve. This systematic review aims to evaluate the effectiveness of the use of AI and ML when applied to public health interventions to contain the spread of SARS-CoV-2. Our findings showed that quarantine should be the best strategy for containing COVID-19. Nationwide lockdown also showed positive impact, whereas social distancing should be considered to be effective only in combination with other interventions including the closure of schools and commercial activities and the limitation of public transportation. Our findings also showed that all the interventions should be initiated early in the pandemic and continued for a sustained period. Despite the study limitation, we concluded that AI and ML could be of help for policy makers to define the strategies for containing the COVID-19 pandemic.


2018 ◽  
Vol 11 (1) ◽  
pp. 111-118 ◽  
Author(s):  
James A. Nichols ◽  
Hsien W. Herbert Chan ◽  
Matthew A. B. Baker

2020 ◽  
Vol 130 ◽  
pp. 109899 ◽  
Author(s):  
Ioannis Antonopoulos ◽  
Valentin Robu ◽  
Benoit Couraud ◽  
Desen Kirli ◽  
Sonam Norbu ◽  
...  

2019 ◽  
Vol 12 (2) ◽  
pp. 156-164 ◽  
Author(s):  
Nick M Murray ◽  
Mathias Unberath ◽  
Gregory D Hager ◽  
Ferdinand K Hui

Background and purposeAcute stroke caused by large vessel occlusions (LVOs) requires emergent detection and treatment by endovascular thrombectomy. However, radiologic LVO detection and treatment is subject to variable delays and human expertise, resulting in morbidity. Imaging software using artificial intelligence (AI) and machine learning (ML), a branch of AI, may improve rapid frontline detection of LVO strokes. This report is a systematic review of AI in acute LVO stroke identification and triage, and characterizes LVO detection software.MethodsA systematic review of acute stroke diagnostic-focused AI studies from January 2014 to February 2019 in PubMed, Medline, and Embase using terms: ‘artificial intelligence’ or ‘machine learning or deep learning’ and ‘ischemic stroke’ or ‘large vessel occlusion’ was performed.ResultsVariations of AI, including ML methods of random forest learning (RFL) and convolutional neural networks (CNNs), are used to detect LVO strokes. Twenty studies were identified that use ML. Alberta Stroke Program Early CT Score (ASPECTS) commonly used RFL, while LVO detection typically used CNNs. Image feature detection had greater sensitivity with CNN than with RFL, 85% versus 68%. However, AI algorithm performance metrics use different standards, precluding ideal objective comparison. Four current software platforms incorporate ML: Brainomix (greatest validation of AI for ASPECTS, uses CNNs to automatically detect LVOs), General Electric, iSchemaView (largest number of perfusion study validations for thrombectomy), and Viz.ai (uses CNNs to automatically detect LVOs, then automatically activates emergency stroke treatment systems).ConclusionsAI may improve LVO stroke detection and rapid triage necessary for expedited treatment. Standardization of performance assessment is needed in future studies.


2018 ◽  
Vol 4 (5) ◽  
pp. 443-463
Author(s):  
Jim Shook ◽  
Robyn Smith ◽  
Alex Antonio

Businesses and consumers increasingly use artificial intelligence (“AI”)— and specifically machine learning (“ML”) applications—in their daily work. ML is often used as a tool to help people perform their jobs more efficiently, but increasingly it is becoming a technology that may eventually replace humans in performing certain functions. An AI recently beat humans in a reading comprehension test, and there is an ongoing race to replace human drivers with self-driving cars and trucks. Tomorrow there is the potential for much more—as AI is even learning to build its own AI. As the use of AI technologies continues to expand, and especially as machines begin to act more autonomously with less human intervention, important questions arise about how we can best integrate this new technology into our society, particularly within our legal and compliance frameworks. The questions raised are different from those that we have already addressed with other technologies because AI is different. Most previous technologies functioned as a tool, operated by a person, and for legal purposes we could usually hold that person responsible for actions that resulted from using that tool. For example, an employee who used a computer to send a discriminatory or defamatory email could not have done so without the computer, but the employee would still be held responsible for creating the email. While AI can function as merely a tool, it can also be designed to act after making its own decisions, and in the future, will act even more autonomously. As AI becomes more autonomous, it will be more difficult to determine who—or what—is making decisions and taking actions, and determining the basis and responsibility for those actions. These are the challenges that must be overcome to ensure AI’s integration for legal and compliance purposes.


2021 ◽  
Vol 4 ◽  
Author(s):  
Lindsay Wells ◽  
Tomasz Bednarz

Research into Explainable Artificial Intelligence (XAI) has been increasing in recent years as a response to the need for increased transparency and trust in AI. This is particularly important as AI is used in sensitive domains with societal, ethical, and safety implications. Work in XAI has primarily focused on Machine Learning (ML) for classification, decision, or action, with detailed systematic reviews already undertaken. This review looks to explore current approaches and limitations for XAI in the area of Reinforcement Learning (RL). From 520 search results, 25 studies (including 5 snowball sampled) are reviewed, highlighting visualization, query-based explanations, policy summarization, human-in-the-loop collaboration, and verification as trends in this area. Limitations in the studies are presented, particularly a lack of user studies, and the prevalence of toy-examples and difficulties providing understandable explanations. Areas for future study are identified, including immersive visualization, and symbolic representation.


Sign in / Sign up

Export Citation Format

Share Document